C1420679||Tead1
C0017262||expression
C1418677||Peripheral Myelin Protein 22
C1817645||Schwann cell development
C0036387||Schwann cells
C0027836||myelinating glia
C0206417||peripheral nervous system
C0026973||myelin sheath
C0031117||peripheral neuropathy
C1511518||copy number variant
C1418677||Peripheral Myelin Protein 22 (PMP22) gene
C0017261||duplication
C0008659||chromosome 17
C0007959||Charcot-Marie-Tooth Disease
C0007959||CMT1A
C1519106||Rodent models
C0007959||CMT1A
C1418677||Pmp22
C0017262||overexpression
C0007959||CMT1A
C2603343||studies
C1418677||Pmp22
C0017263||regulation
C0014290||enhancers
C1571654||sex determining region Y-box 10
C1571654||SRY sex determining region Y-box 10
C0064419||Egr2
C0064419||Krox20
C0064419||Early growth response protein 2
C0040648||transcription factors
C0027750||myelinated nerves
C0040648||transcription factors
C1418677||Pmp22
C0017262||expression
C1817645||Schwann cell development
C0596991||myelination
C1418677||Pmp22
C0014290||enhancers
C1148560||cell type-specificity
C0161479||nerve injury
C1418677||Pmp22
C0014290||enhancers
C1156199||histone modifications
C3263723||injury
C0014290||enhancers
C1418677||Pmp22
C0041904||upregulation
C1418677||Pmp22
C0014290||enhancers
C1956035||binding motifs
C0220134||TEA domain
C0220134||TEA domain
C0040648||transcription factors
C3158583||Hippo signaling pathway
C1420679||Tead1
C1424135||Yap
C1336578||Taz
C1418677||Pmp22
C0017262||expression
C0017262||expression
C1414315||Egr2
C1420679||Tead1
C1418677||Pmp22
C1414315||Egr2
C0014290||enhancers
C1420679||Tead1
C1167622||binding
C0596991||myelination
C1418677||Pmp22
C0017262||expression
C1420679||Tead1
C0017362||regulator
C1418677||Pmp22
C0017262||expression
C1420317||sex determining region Y-box 10
C1414315||Egr2